Vasile Carmen-Cristina, Gheorghe Luisa-Andreea, Chivu Carmen-Daniela, Anghel Marta Ana Maria, Mîinea Ștefan Eduard, Pițigoi Daniela, Crăciun Maria-Dorina
Department of Epidemiology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
National Institute for Infectious Diseases "Prof. Dr. Matei Balș", 021105 Bucharest, Romania.
Microorganisms. 2024 Dec 3;12(12):2490. doi: 10.3390/microorganisms12122490.
infection (CDI) is one of the main causes of morbidity associated with antibiotic use, producing both healthcare-associated infections and community infections. This study aims to describe the epidemiological characteristics, the clinical outcomes, previous antibiotic exposure, and other risk factors of hospitalized patients with CDI in a tertiary infectious disease hospital in Bucharest, Romania. We performed a descriptive analysis based on four-year surveillance data, collected in a tertiary infectious disease hospital in Bucharest, Romania. The annual incidence of CDIs varied from 65.1 cases per 10,000 discharges in 2020 to 211.7 cases per 10,000 discharges in 2023, with a continuously ascending trend. Most of the cases were hospital-acquired cases. There was a high share of antibiotic consumption three months before admission (61.3%). Third-generation cephalosporins, β-lactams with inhibitor combination, and carbapenems were the most used antibiotics, with shares of 46.0%, 25.2%, and 18.6%, respectively. Hospitalization in the previous 12 months and contact with a confirmed CDI case were other frequent factors in the study group, the occurrences of which were recorded as 66.2% and 2.4%, respectively. The surveillance data identified that the annual trend in CDIs is very variable, suggesting the need for continuous and multiannual analysis.
艰难梭菌感染(CDI)是与抗生素使用相关的主要发病原因之一,可导致医疗保健相关感染和社区感染。本研究旨在描述罗马尼亚布加勒斯特一家三级传染病医院中CDI住院患者的流行病学特征、临床结局、既往抗生素暴露情况及其他风险因素。我们基于在罗马尼亚布加勒斯特一家三级传染病医院收集的四年监测数据进行了描述性分析。CDI的年发病率从2020年的每10000例出院患者65.1例变化至2023年的每10000例出院患者211.7例,呈持续上升趋势。大多数病例为医院获得性病例。入院前三个月抗生素使用率较高(61.3%)。第三代头孢菌素、β-内酰胺类与抑制剂联合制剂以及碳青霉烯类是最常用的抗生素,其使用率分别为46.0%、25.2%和18.6%。研究组中,前12个月内住院以及接触确诊的CDI病例是其他常见因素,其发生率分别记录为66.2%和2.4%。监测数据表明,CDI的年度趋势变化很大,这表明需要进行持续的多年分析。